India's Lupin eyes 15 new drug launches in U.S. by March 2013
MUMBAI Oct 23 (Reuters) - Indian drugmaker Lupin plans to launch at least 15 new generic products in the United States in the current fiscal year ending March 2013, as it looks to push up sales in the world's biggest drug market, a top executive said on Tuesday.
"About eight to 10 (from the 15), I would say, will be oral contraceptives," Vinita Gupta, chief executive of Lupin's U.S. unit, told Reuters.
Lupin has launched five products in the U.S. this fiscal year.
The drugmaker had said earlier its September quarter net profit rose 9 percent to 2.91 billion rupees ($54.32 million) to beat analyst estimates.
- Obama and Castro shake hands, Zuma humiliated at Mandela memorial |
- Google bus blocked in San Francisco gentrification protest
- Reporter can keep sources secret in Colorado theater shooting: court
- Regulators seek to curb Wall St. trades with Volcker rule |
- Thai PM urges protesters to take part in election |